Home Genome Editing Gene Therapy

Gene Therapy

    Latest
    brain and DNA
    Gene Therapy

    Gene Therapy Production and Quality Control

    Gene Therapy

    FDA Places Another Clinical Hold on Trial for Solid’s DMD Gene...

    Adeno-associated virus, illustration
    Gene Therapy

    Several Age-Related Diseases, One Gene Therapy Combo, Multiple Improvements

    Gene Therapy

    CRISPR is Editing its Way Toward Cell and Gene Therapy

    Gene Therapy

    FDA Places Partial Clinical Hold on Some Trials of Novartis Gene...

    Firms will also work together to develop diagnostics over the next two and a half years. [© AlienForce - Fotolia.com]
    Gene Therapy

    On Higher Ground: The Dilemma on Gene Therapy Pricing

    ESGCT 2019
    Gene Therapy

    Promising Results Reported in Tay-Sachs Gene Therapy Trial

    Spark Therapeutics saw its share price tumble about 30% in early-morning trading after it reported mixed preliminary data this morning from a Phase I/II trial of its hemophilia A gene therapy candidate SPK-8001. [Source: wildpixel/Getty Images]
    Gene Therapy

    Novel Gene Therapy for Duchenne Muscular Dystrophy Shows Promise

    Gene Therapy

    Lonza, Prevail Therapeutics Partner on Gene Therapy Manufacturing

    Gene Therapy

    Gene Therapy Vehicle for Sickle-Cell Disease Shifts Forward

    Load more

    Recently Featured

    Stay Connected

    555,258FansLike
    49,065FollowersFollow
    Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
    Scroll Up